Floatz logo

Valproic Acid

Bipolar 1 Disorder

OPKO Health, Inc.Small moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

34 Active assets in the Bipolar 1 Disorder cohort.

Asset / SponsorPhaseRating
Lurasidone
Massachusetts General Hospital
Phase 4BBB
LITHIUM, ELEMENTAL
Alzamend Neuro, Inc.
Phase 4BBB
Cipralex
Massachusetts General Hospital
Phase 4BBB
Olanzapine
Alkermes, Inc.
Phase 4BBB
Valproic Acid
Bristol-Myers Squibb
Phase 4BBB

View all 50 →

Same molecule, other indications

Valproic Acid is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
74 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
73 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →